Skip to Content

Amiodarone Injection

Last Updated: June 6, 2018
Status: Current

Products Affected - Description
    • Amiodarone injection, Mylan Institutional, 50 mg/mL, 3 mL vial, 10 count, NDC 67457-0153-03
    • Amiodarone injection, Mylan Institutional, 50 mg/mL, 9 mL vial, 10 count, NDC 67457-0153-09
Reason for the Shortage
    • Baxter had Nexterone premixed bags on shortage due to manufacturing delays.
    • Mylan Institutional did not provide a reason for the shortage.
    • West-Ward did not provide a reason for the shortage.
Available Products
    • Nexterone injection, Baxter, 150 mg/100 mL, premixed bag, 12 count, NDC 43066-0150-10
    • Nexterone injection, Baxter, 360 mg/200 mL, premixed bag, 10 count, NDC 43066-0360-20
    • Amiodarone injection, Fresenius Kabi, 50 mg/mL, 3 mL vial, 10 count, NDC 63323-0616-03
    • Amiodarone injection, Fresenius Kabi, 50 mg/mL, 9 mL vial, 10 count, NDC 63323-0616-09
    • Amiodarone injection, Mylan Institutional, 50 mg/mL, 18 mL vial, 10 count, NDC 67457-0153-18
    • Amiodarone injection, Sagent, 50 mg/mL, 3 mL syringe, 10 count, NDC 25021-0302-66
    • Amiodarone injection, West-Ward, 50 mg/mL, 3 mL vial, 10 count, NDC 00143-9875-10
    • Amiodarone injection, West-Ward, 50 mg/mL, 3 mL vial, 25 count, NDC 00143-9875-25

Estimated Resupply Dates

    • Mylan Institutional has amiodarone 50 mg/mL 9 mL vials available that expire February 28, 2019. Amiodarone 50 mg/mL 3 mL vials are on back order and the company estimates a release date of late-June 2018.

Updated

Updated June 6, 2018 by Megan Dryer, PharmD. Created January 6, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. Copyright 2018, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide